Rutgers Health Radiology offers a comprehensive approach to the imaging diagnosis of liver disease and tumors, including hepatocellular carcinoma, a primary cancer of liver cell. We offer multiple imaging modalities including ultrasound, CT scan, and MRI to accurately diagnose and stage patients with cirrhosis due to non-alcoholic steatohepatitis (NASH), Hepatitis B and C, and alcohol-related liver disease.

Our diagnostic radiologists are integral members of the health care team and actively participate in multidisciplinary conferences in which patient treatment is decided, including eligibility for liver transplant. We report all liver lesions utilizing the American College of Radiology’s (ACR) Liver Imaging Reporting and Data System (LI-RADS) to provide the most accurate and consistent assessment of liver tumor burden.

Our radiologists have advanced subspecialty training in the diagnosis of liver disease and attend continuing education courses to remain at the forefront of liver imaging. We utilize customized protocols for the CT and MR evaluation of liver tumors, including benign liver tumors (focal nodular hyperplasia, hepatic adenoma, and hepatic hemangioma) and malignant liver tumors (hepatocellular carcinoma, cholangiocarcinoma, and metastatic disease to the liver). Our tailored approach to liver imaging often assists us in making a definitive diagnosis of the type of liver tumor without subjecting the patient to a biopsy.

If you or a loved one requires liver imaging services, please contact Rutgers Health Radiology for an appointment.